Sjögren's disease trials in Australia

In Australia 7 Also abroad 80

7 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Where
Maroochydore
Age
18 years and over
People
570 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07621809 · EU 2025-522271-29-00
Phase 2Taking people
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Where
Nedlands, Southport
Age
18 years to 100 years
People
344 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07737743 · EU 2025-524513-92-00
Phase 1Taking people
A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body
Where
Brisbane
Age
18 years to 75 years
People
63
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT07649265
Phase 2Taking people
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
Where
Brisbane, Maroochydore, Melbourne, Sydney
Age
18 years to 80 years
People
80
Run by
Lubris Bio Pty Ltd
See details and how to joinNCT07118241
Phase 1Taking people
A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases
Where
Melbourne
Age
18 years to 65 years
People
105
Run by
Candid Therapeutics
See details and how to joinNCT07712939
Phase 1Taking people
A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
Where
Melbourne
Age
18 years to 75 years
People
60
Run by
Xencor, Inc.
See details and how to joinNCT07284797
Phase 3Taking people
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Where
Woodville South
Age
18 years and over
People
844 worldwide
Run by
Amgen
See details and how to joinNCT06747949 · EU 2024-517513-32-00